Justin B. Klee - Co-Chief Executive Officer, Director at Amylyx Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Co-Chief Executive Officer, Director
Stock Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Justin B. Klee - trading volume in the past year for Amylyx Pharmaceuticals, Inc.

Holdings reported by Justin B. Klee for Amylyx Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.36M $11.6M $3.46 Mar 31, 2025 Direct
Stock Option (right to buy) 270K Mar 6, 2025 Direct Common Stock

Transactions reported by Justin B. Klee for Amylyx Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.